Cumulus Exists to Reduce Uncertainty in Neuroscience.
For too long, CNS drug development has been hampered by invisible signals, placebo effects, heterogeneity in symptoms and in patients, and overly subjective endpoints.
Cumulus Neuroscience
Cumulus exists to reduce uncertainty in neuroscience.
For too long, CNS drug development has been hampered by invisible signals, placebo effects, heterogeneity in symptoms and in patients, and overly subjective endpoints.
Research Partners
The Neulogiq Platform was Designed for use in CNS Clinical Studies in Collaboration with 10 Top Pharma Companies.
Neulogiq provides frequent, reliable in-clinic and at-home longitudinal monitoring of discrete brain functions.
Easy-to-use measurement tools that patients want to engage with.
Built for Researchers
Reliable, repeatable brain function data you can trust.
Made for Real-World Studies
Engaging multi-modal assessments for use in-clinic or at home, unified in one platform.
The NeuLogiq Platform is Designed for Use in Clinical Trials with Top 10 Pharma Advisory Group.
NeuLogiq provides continuous, real-world monitoring of brain function, combining digital assessments and neurophysiological data to support CNS drug development.
Easy-to-use measurement tools that patients want to engage with.
Built for Researchers
Reliable, repeatable brain function data you can trust.
Made for Real-World Studies
Engaging multi-modal assessments for use in-clinic or at-home, unified in one platform.
Accessible
Overcome accessibility issues with a low-burden, engaging platform that makes clinical trials more accessible, improving overall experience and trial participation.
Data Rich
Get deep insights from multi-modal digitised assessments of objective and sensitive measures. Endpoints that are meaningful to patients.
Scalable
Remove limitations with non-invasive, repeated objective measures of target engagement and treatment effects in-clinic or at-home, on a single platform.
Optimised Trials
Achieve more data per participant, enabling the powering of smaller studies, and earlier decision-making, reducing trial costs.
